What are the sequelae of chemotherapy for colon cancer

As a common malignant tumor in daily life, it is important to receive timely treatment after the disease is discovered. Radiotherapy and chemotherapy are commonly used treatments for colon cancer. However, chemotherapy for colon cancer often causes certain damage to the human immune system, resulting in a series of chemotherapy complications, and reduces the body's ability to resist diseases, making it easy to be invaded by various diseases. So, what are the sequelae of radiotherapy and chemotherapy for colon cancer?

After chemotherapy for colon cancer, most patients will experience symptoms such as nausea, vomiting, loss of appetite, weight loss, and sputum. The short-term effect of chemotherapy is relatively good, but the toxic side effects of chemotherapy are very large, which will kill normal cells, inhibit bone marrow hematopoiesis, and cause nausea, vomiting, hair loss, infection, bleeding and other symptoms. At present, the effect of traditional Chinese medicine treatment for the toxic side effects of chemotherapy is very significant, and traditional Chinese medicine can improve the body's immunity.

1. Fatigue: This is one of the sequelae of radiotherapy (chemotherapy). During radiotherapy (chemotherapy), the human body consumes a lot of energy and needs to use its own immune system to regulate. Most colorectal cancer patients will feel tired after a few weeks of radiotherapy (chemotherapy), and they will feel more tired as the radiotherapy continues.

2. Dry skin: The skin at the treated area is sensitive and looks red and wrinkled. After a few weeks, the skin of colorectal cancer patients becomes dry due to radiotherapy and chemotherapy. Most skin reactions will disappear a few weeks after the end of radiotherapy and chemotherapy.

3. Decreased blood cells: If the patient's blood test shows that chemotherapy has reduced the white blood cell count or platelet count, treatment will be suspended for one week to increase the blood cell count of colorectal cancer patients.